Border to Coast Pensions Partnership Ltd Lowers Stock Holdings in UnitedHealth Group Incorporated $UNH

Border to Coast Pensions Partnership Ltd lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.4% during the first quarter, HoldingsChannel reports. The firm owned 179,621 shares of the healthcare conglomerate’s stock after selling 27,717 shares during the quarter. Border to Coast Pensions Partnership Ltd’s holdings in UnitedHealth Group were worth $48,753,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the business. Sarver Vrooman Wealth Advisors acquired a new stake in UnitedHealth Group in the 4th quarter worth about $25,000. Beacon Financial Strategies CORP purchased a new position in shares of UnitedHealth Group during the 4th quarter worth about $26,000. Anfield Capital Management LLC grew its holdings in UnitedHealth Group by 220.0% in the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 55 shares during the period. Joseph Group Capital Management acquired a new position in UnitedHealth Group during the fourth quarter worth approximately $27,000. Finally, Nalls Sherbakoff Group LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $27,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 2.9%

Shares of UNH opened at $427.47 on Friday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $427.93. The stock’s 50-day moving average is $383.92 and its two-hundred day moving average is $332.44. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.80. The stock has a market cap of $388.21 billion, a PE ratio of 32.29, a P/E/G ratio of 1.72 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating the consensus estimate of $6.76 by $0.47. The business had revenue of $111.65 billion for the quarter, compared to the consensus estimate of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The company’s revenue was up 2.0% on a year-over-year basis. During the same period last year, the business posted $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 18.32 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th were paid a $2.32 dividend. This represents a $9.28 annualized dividend and a dividend yield of 2.2%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. The ex-dividend date was Monday, June 15th. UnitedHealth Group’s payout ratio is currently 70.09%.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the sale, the chief executive officer owned 17,805 shares of the company’s stock, valued at $6,320,775. The trade was a 4.30% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.28% of the stock is owned by company insiders.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Wall Street sentiment remains constructive, with multiple firms reiterating bullish ratings and several recent price-target increases, including a new $475 target from BofA Securities. That suggests analysts see room for further upside as margins and Optum Health improve. What to Expect From UnitedHealth Group’s Q2 2026 Earnings Report
• Positive Sentiment: Investors appear to be rotating into healthcare as a defensive play while technology stocks weaken, which is supporting demand for UNH shares. Social-media chatter also points to continued interest in the company’s recovery narrative and its resilient insurance and medical-services business. UnitedHealth Group Stock (UNH) Opinions on Market Rotation and Analyst Upgrades
• Positive Sentiment: Market coverage ahead of the Q2 2026 report says analysts expect double-digit EPS growth, reinforcing the idea that earnings could justify the stock’s recent move higher. What to Expect From UnitedHealth Group’s Q2 2026 Earnings Report
• Neutral Sentiment: Recent articles also frame UNH as a long-term value and healthcare watchlist name, which supports investor interest but does not by itself add a fresh catalyst.

Analysts Set New Price Targets

A number of analysts have recently commented on UNH shares. JPMorgan Chase & Co. upped their price objective on UnitedHealth Group from $420.00 to $466.00 and gave the stock an “overweight” rating in a report on Monday, June 8th. Sanford C. Bernstein restated an “outperform” rating on shares of UnitedHealth Group in a research note on Tuesday. HC Wainwright set a $492.00 price objective on UnitedHealth Group in a research note on Wednesday, May 27th. TD Cowen reissued a “buy” rating on shares of UnitedHealth Group in a research report on Monday, June 22nd. Finally, Royal Bank Of Canada lifted their price target on shares of UnitedHealth Group from $361.00 to $400.00 and gave the company an “outperform” rating in a research report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $410.79.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.